1. Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice and ferrets;Aoki;J Pharmacol Exp Ther,2000
2. Novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1,7 diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity;Aoki;J Pharmacol Exp Ther,2000
3. Studies on mechanism of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor;Aoki;J Pharmacol Exp Ther,2001
4. Late and prolonged post-training memory modulation in entorhinal and parietal cortex by drugs acting on the cAMP/protein kinase A signaling pathway;Ardenghi;Behav Pharmacol,1997
5. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory;Barad;P Natl Acad Sci USA,1998